Trastuzumab Emtansine: A Novel Antibody-Drug Conjugate for HER2-Positive Breast CancerKROP, Ian; WINER, Eric P.Clinical cancer research (Print). 2014, Vol 20, Num 1, pp 15-20, issn 1078-0432, 6 p.Article

Primary care for survivors of breast cancerBURSTEIN, Harold J; WINER, Eric P.The New England journal of medicine. 2000, Vol 343, Num 15, pp 1086-1094, issn 0028-4793Article

Pertuzumab: Optimizing HER2 BlockadeMETZGER-FILHO, Otto; WINER, Eric P; KROP, Ian et al.Clinical cancer research (Print). 2013, Vol 19, Num 20, pp 5552-5556, issn 1078-0432, 5 p.Article

Hormonal therapy in postmenopausal women with breast cancerCAMPOS, Susana M; WINER, Eric P.Oncology. 2003, Vol 64, Num 4, pp 289-299, issn 0030-2414, 11 p.Article

New combinations with Herceptin® in metastatic breast cancerWINER, Eric P; BURSTEIN, Harold J.Oncology. 2001, Vol 61, pp 50-57, issn 0030-2414, SUP2Conference Paper

Brain metastases : The HER2 paradigm : CNS metastasis: An old problem in a new guiseLIN, Nancy U; WINER, Eric P.Clinical cancer research. 2007, Vol 13, Num 6, pp 1648-1655, issn 1078-0432, 8 p.Article

Long-term complications of adjuvant chemotherapy for early stage breast cancerPARTRIDGE, Ann H; WINER, Eric P.Breast disease. 2004, Vol 21, pp 55-64, issn 0888-6008, 10 p.Article

Liposomal anthracyclines for breast cancerSPARANO, Joseph A; WINER, Eric P.Seminars in oncology. 2001, Vol 28, Num 4, pp 32-40, issn 0093-7754, SUP12Article

Complementary and alternative medicine use among women with breast cancerDIGIANNI, Lisa M; GARBER, Judy E; WINER, Eric P et al.Journal of clinical oncology. 2002, Vol 20, Num 18, pp 34s-38s, issn 0732-183X, SUPArticle

Cancer and leukemia Group B breast committee : Decades of progress and plans for the futureHUDIS, Clifford A; WINER, Eric P.Clinical cancer research. 2006, Vol 12, Num 11, issn 1078-0432, 3576s-3580s, 2Article

CNS metastases in breast cancerLIN, Nancy U; BELLON, Jennifer R; WINER, Eric P et al.Journal of clinical oncology. 2004, Vol 22, Num 17, pp 3608-3617, issn 0732-183X, 10 p.Article

New cytotoxic agents and schedules for advanced breast cancerBURSTEIN, Harold J; BUNNELL, Craig A; WINER, Eric P et al.Seminars in oncology. 2001, Vol 28, Num 4, pp 344-358, issn 0093-7754Article

Quality of life issues among women undergoing high-dose chemotherapy for breast cancerPARTRIDGE, Ann H; BUNNELL, Craig A; WINER, Eric P et al.Breast disease. 2001, Vol 14, pp 41-50, issn 0888-6008Article

Trastuzumab/chemotherapy combinations in metastatic breast cancerLIGIBEL, Jennifer A; WINER, Eric P.Seminars in oncology. 2002, Vol 29, Num 3, pp 38-43, issn 0093-7754, SUP11Article

Effect of Massachusetts Health Insurance Reform on Mammography Use and Breast Cancer Stage at DiagnosisKEATING, Nancy L; KOURI, Elena M; YULEI HE et al.Cancer. 2013, Vol 119, Num 2, pp 250-258, issn 0008-543X, 9 p.Article

Follow-up care of breast cancer survivorsPARTRIDGE, Ann H; WINER, Eric P; BURSTEIN, Harold J et al.Seminars in oncology. 2003, Vol 30, Num 6, pp 817-825, issn 0093-7754, 9 p., SUP19Conference Paper

Care in the Months before Death and Hospice Enrollment Among Older Women with Advanced Breast CancerKEATING, Nancy L; LANDRUM, Mary Beth; GUADAGNOLI, Edward et al.Journal of general internal medicine. 2008, Vol 23, Num 1, pp 11-18, issn 0884-8734, 8 p.Article

Local therapy and survival in breast cancerPUNGLIA, Rinaa S; MORROW, Monica; WINER, Eric P et al.The New England journal of medicine. 2007, Vol 356, Num 23, pp 2399-2405, issn 0028-4793, 7 p.Article

Surveillance testing among survivors of early-stage breast cancerKEATING, Nancy L; LANDRUM, Mary Beth; GUADAGNOLI, Edward et al.Journal of clinical oncology. 2007, Vol 25, Num 9, pp 1074-1081, issn 0732-183X, 8 p.Article

The Role of Socioeconomic Status in Adjustment After Ductal Carcinoma In SituDE MOOR, Janet S; PARTRIDGE, Ann H; WINER, Eric P et al.Cancer. 2010, Vol 116, Num 5, pp 1218-1225, issn 0008-543X, 8 p.Article

Summary of Aromatase Inhibitor Clinical Trials in Postmenopausal Women With Early Breast CancerBUZDAR, Aman U; COOMBES, R. Charles; GOSS, Paul E et al.Cancer. 2008, Vol 112, Num 3, pp 700-709, issn 0008-543X, 10 p., SUPConference Paper

Pharmacogenomic Variation of CYP2D6 and the Choice of Optimal Adjuvant Endocrine Therapy for Postmenopausal Breast Cancer : A Modeling AnalysisPUNGLIA, Rinaa S; BURSTEIN, Harold J; WINER, Eric P et al.Journal of the National Cancer Institute. 2008, Vol 100, Num 9, pp 642-648, issn 0027-8874, 7 p.Article

Factors related to underuse of surveillance mammography among breast cancer survivorsKEATING, Nancy L; LANDRUM, Mary Beth; GUADAGNOLI, Edward et al.Journal of clinical oncology. 2006, Vol 24, Num 1, pp 85-94, issn 0732-183X, 10 p.Article

Trends in Racial and Age Disparities in Definitive Local Therapy of Early-Stage Breast CancerFREEDMAN, Rachel A; YULEI HE; WINER, Eric P et al.Journal of clinical oncology. 2009, Vol 27, Num 5, pp 713-719, issn 0732-183X, 7 p.Article

Quality of non-breast cancer health maintenance among elderly Breast cancer survivorsEARLE, Craig C; BURSTEIN, Harold J; WINER, Eric P et al.Journal of clinical oncology. 2003, Vol 21, Num 8, pp 1447-1451, issn 0732-183X, 5 p.Article